Schonfeld Strategic Advisors LLC Assembly Biosciences, Inc. Transaction History

Schonfeld Strategic Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.33 - $6.63 $1.3 Million - $1.99 Million	-299,865 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.87 - $17.29 $1.46 Million - $5.18 Million	299,865 New	299,865 $1.82 Million
Q1 2020 May 15, 2020	SELL	$10.27 - $21.23 $369,596 - $764,025	-35,988 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.36 - $23.81 $300,859 - $856,874	35,988 New	35,988 $736,000
Q1 2019 May 15, 2019	SELL	$17.7 - $24.93 $545,160 - $767,844	-30,800 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$19.05 - $36.45 $243,840 - $466,560	-12,800 Reduced 29.36%	30,800 $697,000
Q3 2018 Nov 14, 2018	SELL	$34.41 - $44.23 $82,583 - $106,151	-2,400 Reduced 5.22%	43,600 $1.62 Million
Q2 2018 Aug 14, 2018	BUY	$39.21 - $50.29 $1.24 Million - $1.59 Million	31,660 Added 220.78%	46,000 $1.8 Million
Q1 2018 May 15, 2018	BUY	$41.7 - $64.16 $597,978 - $920,054	14,340 New	14,340 $704,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $723M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.